This is an amended first competitive renewal to support the Training Program in Cancer Biology, centered within the Hematology-Oncology Division of Beth Israel-Deaconess Medical Center (BIDMC), which offers support to MD, MD/PhD, and PhD post-doctoral fellows (total of 8). We provide a multi-disciplinary program consisting of didactic instruction, ongoing journal clubs, seminars and retreats, and laboratory research. Important elements of the curriculum include close supervision by faculty advisors and the Training Grant Steering Committee, course work, and frequent interactions amongst trainees and faculty. The program is under the direction of Dr. Benjamin G. Neel, and the Associate Program Directors are Drs. Steven Balk and Michael Atkins. Most trainee faculty are based at BIDMC, within the Medicine and Pathology Departments. Selected faculty from surrounding Harvard Medical School-associated institutions (HMS Cell Biology, Dana-Farber Cancer Institute, Brigham and Women's Hospital) also participate as a consequence of the relevance and strength of their research and training records, and their frequent scientific interactions with BIDMC preceptors. Members of the training faculty have strong records of research accomplishments, well-funded research programs, and extensive and successful training records. Research opportunities for trainees are organized into five focus areas: Signal Transduction/Cell Cycle Control, Angiogenesis, Leukemogenesis/ Lymphomagenesis, Epithelial Cell Biology/Carcinogenesis, and Immunobiology/lmmunotherapy. During the 5 years of this program, we have supported 23 highly selected investigators with great promise for future contributions to oncology research. Relevance: The overarching principle guiding the program is that for rapid translation of basic research findings to the bedside, it is vital that clinicians receive broad and deep training in modern biological research, while Ph.D. researchers supplement their training with insights into cancer pathobiology. We anticipate that our program will allow our trainees who eventually focus on patient care to develop molecular based clinical trials with robust translational components, while encouraging our basic science trainees to interact with oncologists and apply their expertise to problems of immediate relevance to cancer patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA081156-10
Application #
8089417
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
2000-04-01
Project End
2012-06-30
Budget Start
2011-07-01
Budget End
2012-06-30
Support Year
10
Fiscal Year
2011
Total Cost
$315,980
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Sowalsky, Adam G; Kissick, Haydn T; Gerrin, Sean J et al. (2017) Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4. Clin Cancer Res 23:3823-3833
Cleland, Timothy P; Schroeter, Elena R; Zamdborg, Leonid et al. (2015) Mass Spectrometry and Antibody-Based Characterization of Blood Vessels from Brachylophosaurus canadensis. J Proteome Res 14:5252-62
Chen, Eddy J; Sowalsky, Adam G; Gao, Shuai et al. (2015) Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors. Clin Cancer Res 21:1273-80
Sowalsky, Adam G; Xia, Zheng; Wang, Liguo et al. (2015) Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Mol Cancer Res 13:98-106
Willis, Nicholas A; Chandramouly, Gurushankar; Huang, Bin et al. (2014) BRCA1 controls homologous recombination at Tus/Ter-stalled mammalian replication forks. Nature 510:556-9
Chin, Y Rebecca; Yoshida, Taku; Marusyk, Andriy et al. (2014) Targeting Akt3 signaling in triple-negative breast cancer. Cancer Res 74:964-73
Chin, Y Rebecca; Yuan, Xin; Balk, Steven P et al. (2014) PTEN-deficient tumors depend on AKT2 for maintenance and survival. Cancer Discov 4:942-55
Duncan, Michael B; Yang, Changqing; Tanjore, Harikrishna et al. (2013) Type XVIII collagen is essential for survival during acute liver injury in mice. Dis Model Mech 6:942-51
Chandramouly, Gurushankar; Kwok, Amy; Huang, Bin et al. (2013) BRCA1 and CtIP suppress long-tract gene conversion between sister chromatids. Nat Commun 4:2404
Sowalsky, Adam G; Ye, Huihui; Bubley, Glenn J et al. (2013) Clonal progression of prostate cancers from Gleason grade 3 to grade 4. Cancer Res 73:1050-5

Showing the most recent 10 out of 27 publications